We are delighted to announce the release of ChEMBL 34, which includes a full update to drug and clinical candidate drug data. This version of the database, prepared on 28/03/2024 contains: 2,431,025 compounds (of which 2,409,270 have mol files) 3,106,257 compound records (non-unique compounds) 20,772,701 activities 1,644,390 assays 15,598 targets 89,892 documents Data can be downloaded from the ChEMBL FTP site: https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/ Please see ChEMBL_34 release notes for full details of all changes in this release: https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_34/chembl_34_release_notes.txt New Data Sources European Medicines Agency (src_id = 66): European Medicines Agency's data correspond to EMA drugs prior to 20 January 2023 (excluding vaccines). 71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g.
If you have a question about the data in ChEMBL you might consider visiting our FAQ page! We have recently expanded and updated the FAQs; we have included more intuitive categories, mirroring the organisation of our data. Enquiries are now sorted into general, assay and activity, drug and compound, target, document and data source, interface, download, and schema questions. We have added new answers, including to the questions: How are [protein] isoforms treated by ChEMBL? What are the parameters for the [structure] similarity search? Can you provide more details on ChEMBL releases? Does ChEMBL contain agrochemical data? Our FAQs are searchable, making it easy to navigate to your area of interest. You can also find help with programmatic access to the database , and a guide to our web interface . If you want to keep up to date with ChEMBL news and data releases you can subscribe to the Chembl-announce mailing list. For any questions not answered by our FAQs, please email chemb